Johnson Matthey Acquires Solid State Chemistry Specialist Pharmorphix
Johnson Matthey has acquired the Pharmorphix solid form research business from Sigma-Aldrich. The acquisition provides Johnson Matthey with material science capabilities for its European active pharmaceutical ingredient and clinical supply services.
Pharmorphix, based in Cambridge, the UK, is a provider of solid form services, including polymorph studies, salt selection, co-crystallization, chiral separations, and process scale-up. The Pharmorphix facilities and staff are located at the Cambridge Science Park, where they will be integrated into Johnson Matthey's expanding Cambridge presence.
Source: Johnson & Matthey